Unrecognized Tax Benefits of SUPERNUS PHARMACEUTICALS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
SUPERNUS PHARMACEUTICALS, INC. quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • SUPERNUS PHARMACEUTICALS, INC. Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $13,991,000, a 140% increase year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

SUPERNUS PHARMACEUTICALS, INC. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $13,991,000 +$8,151,000 +140% 31 Dec 2025 10-K 02 Mar 2026 2025 FY
Q4 2024 $5,840,000 +$3,691,000 +172% 31 Dec 2024 10-K 02 Mar 2026 2025 FY
Q4 2023 $2,149,000 -$2,174,000 -50% 31 Dec 2023 10-K 02 Mar 2026 2025 FY
Q4 2022 $4,323,000 -$1,777,000 -29% 31 Dec 2022 10-K 02 Mar 2026 2025 FY
Q4 2021 $6,100,000 +$219,000 +3.7% 31 Dec 2021 10-K 25 Feb 2025 2024 FY
Q4 2020 $5,881,000 -$97,000 -1.6% 31 Dec 2020 10-K 09 Mar 2023 2022 FY
Q4 2019 $5,978,000 -$2,870,000 -32% 31 Dec 2019 10-K 09 Mar 2023 2022 FY
Q4 2018 $8,848,000 -$11,000 -0.12% 31 Dec 2018 10-K 13 Apr 2022 2021 FY
Q4 2017 $8,859,000 -$440,000 -4.7% 31 Dec 2017 10-K 08 Mar 2021 2020 FY
Q4 2016 $9,299,000 -$42,000 -0.45% 31 Dec 2016 10-K 28 Feb 2020 2019 FY
Q4 2015 $9,341,000 +$377,000 +4.2% 31 Dec 2015 10-K 01 Mar 2019 2018 FY
Q4 2014 $8,964,000 -$864,000 -8.8% 31 Dec 2014 10-K 01 Mar 2018 2017 FY
Q4 2013 $9,828,000 +$9,140,000 +1328% 31 Dec 2013 10-K 16 Mar 2017 2016 FY
Q4 2012 $688,000 -$64,000 -8.5% 31 Dec 2012 10-K/A 20 Jan 2017 2015 FY
Q4 2011 $752,000 +$110,000 +17% 31 Dec 2011 10-K 12 Mar 2015 2014 FY
Q4 2010 $642,000 31 Dec 2010 10-K 21 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.